Clinical characteristics and prognostic analysis of Krukenberg tumor

被引:51
作者
Wu, Fang [1 ]
Zhao, Xiaoai [1 ]
Mi, Baibing [2 ]
Feng, Lu [1 ]
Yuan, Na [1 ]
Lei, Fuxi [1 ]
Li, Min [1 ]
Zhao, Xinhan [1 ]
机构
[1] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, 227 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710061, Shaanxi, Peoples R China
关键词
Krukenberg tumor; ovarian metastasis; clinical characteristic; overall survival; prognostic factor;
D O I
10.3892/mco.2015.634
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Krukenberg tumor is a rare metastastic tumor of the ovary, characterized by poor prognosis. In order to analyze the clinical characteristics and prognostic factors, we retrospectively investigated 128 patients who were diagnosed with Krukenberg tumor between January, 1990 and December, 2010. The median patient age was 48 years. The median overall survival (OS) of Krukenberg tumor for all patients was 16 months (95% CI: 15-19 months). The median OS among patients with Krukenberg tumors of gastric, colorectal, breast and other origins (including appendix, gallbladder, small intestine and unknown primary) was 11, 21.5, 31 and 19.5 months, respectively (P<0.0001). In the univariate analysis, synchronous metastasis, no chemotherapy, ovarian metastasis beyond the pelvis, ascites and no metastasectomy were identified as significant poor prognostic factors. The multivariate analysis suggested that synchronous metastasis (P=0.0080), pelvic invasion (P=0.0138), ascites (P<0.0001) and no metastasectomy (P=0.0060) were independent factors for predicting unfavorable OS. It was suggested that the prognosis of Krukenberg tumor is dismal and ovarian metastasectomy may prove beneficial. Adequate treatment planning is required for this group of patients.
引用
收藏
页码:1323 / 1328
页数:6
相关论文
共 23 条
[1]  
Al-Agha OM, 2006, ARCH PATHOL LAB MED, V130, P1725
[2]   The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries [J].
Ayhan, A ;
Guvenal, T ;
Salman, MC ;
Ozyuncu, O ;
Sakinci, M ;
Basaran, M .
GYNECOLOGIC ONCOLOGY, 2005, 98 (02) :235-241
[3]   Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer [J].
Cheong, JH ;
Hyung, WJ ;
Chen, J ;
Kim, J ;
Choi, SH ;
Noh, SH .
GYNECOLOGIC ONCOLOGY, 2004, 94 (02) :477-482
[4]   Ovarian metastasis from colorectal cancer: Prognostic value of radical oophorectomy [J].
Erroi, Francesca ;
Scarpa, Marco ;
Angriman, Imerio ;
Cecchetto, Attilio ;
Pasetto, Lara ;
Mollica, Eleonora ;
Bettiol, Marina ;
Ruffolo, Cesare ;
Polese, Lino ;
Cillo, Umberto ;
D'Amico, Davide F. .
JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (02) :113-117
[5]  
Januszewska Malgorzata, 2006, Ginekol Pol, V77, P203
[6]   Surgical treatment for patients with different origins of Krukenberg tumors: Outcomes and prognostic factors [J].
Jiang, R. ;
Tang, J. ;
Cheng, X. ;
Zang, R. Y. .
EJSO, 2009, 35 (01) :92-97
[7]   Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2 [J].
Kauff, Noah D. ;
Barakat, Richard R. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (20) :2921-2927
[8]   Prognostic factors of Krukenberg's tumor [J].
Kim, HK ;
Heo, DS ;
Bang, YJ ;
Kim, NK .
GYNECOLOGIC ONCOLOGY, 2001, 82 (01) :105-109
[9]   Survival benefit of gastrectomy ±A metastasectomy in patients with metastatic gastric cancer receiving chemotherapy [J].
Kim, Ki Hwan ;
Lee, Keun-Wook ;
Baek, Sun Kyung ;
Chang, Hye Jung ;
Kim, Yu Jung ;
Park, Do Joong ;
Kim, Jee Hyun ;
Kim, Hyung-Ho ;
Lee, Jong Seok .
GASTRIC CANCER, 2011, 14 (02) :130-138
[10]   The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries [J].
Kim, Woo Young ;
Kim, Tae-Joong ;
Kim, Sei Eun ;
Lee, Jeong-Won ;
Lee, Je-Ho ;
Kim, Byoung-Gie ;
Bae, Duk-Soo .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 149 (01) :97-101